FDA Inspection 1191374 — Lupin Limited
The FDA completed an inspection of Lupin Limited on Nov 23, 2022 in Mandideep. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Nov 23, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mandideep (India)